Entecavir
- Product NDC
- 0093-5787
- 11-digit product format
- 000935787
- Labeler code
- 0093
- Product ID
- 0093-5787_6b2d566d-fcd9-4913-a6ed-e7697e49101f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Entecavir
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA202122
- Marketing category
- ANDA
- Marketing start
- 2014-09-04
- Marketing end
- 2021-04-30
- Substance
- ENTECAVIR
- Active strength
- 1 mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-5787-56 | 00093578756 | 30 TABLET, FILM COATED in 1 BOTTLE (0093-5787-56) | 2014-09-04 | 2021-04-30 | No | No | Current |